TORIPALIMAB
Clinical trials for TORIPALIMAB explained in plain language.
Never miss a new study
Get alerted when new TORIPALIMAB trials appear
Sign up with your email to follow new studies for TORIPALIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink untreatable esophageal tumors
Disease control Recruiting nowThis study tests whether adding the drug surufatinib to standard chemotherapy, immunotherapy, and radiation can help people with advanced esophageal cancer that cannot be removed by surgery. The goal is to see if this combination can keep the cancer from growing for at least two …
Matched conditions: TORIPALIMAB
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 06, 2026 16:01 UTC
-
Scientists test aggressive Four-Pronged attack on Fast-Moving lung cancer
Disease control Recruiting nowThis study is testing whether adding two newer drugs, toripalimab and surufatinib, to the standard treatment of chemotherapy and radiation can better control limited-stage small cell lung cancer. It will involve about 47 adults with this specific type of cancer that has not sprea…
Matched conditions: TORIPALIMAB
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 20, 2026 16:14 UTC